Several novel methoctramine-related tetraamines were designed, and their biological profiles at muscarinic receptor subtypes were assessed by functional experiments in isolated guinea pig and rat atria (M2) and smooth muscle (ileum and trachea, M3) and by binding assays in rat cortex (M1), heart (M2), and submaxillary gland (M3) homogenates and NG 108-15 cells (M4). Tripitramine, a nonsymmetrical tetraamine, resulted in the most potent and the most selective muscarinic M2 receptor antagonist of the series (pA2 = 9.14-9.85; pKi= 9.54). Spirotramine (FC 15-94), a symmetrical tetraamine, was able to differentiate between muscarinic m1 receptors (pKi = 7.88) and the other subtypes (M2, pKi = 6.20; M3, pKi =5.81; M4 pKi = 6.27). Thus, tripitramine and spirotramine could be valuable tools for the pharmacological classification and characterization of muscarinic receptor subtypes. © 1995.

Melchiorre C., Minarini A., Budriesi R., Chiarini A., Spampinato S., Tumiatti V. (1995). The design of novel methoctramine-related tetraamines as muscarinic receptor subtype selective antagonists. LIFE SCIENCES, 56(11-12), 837-844 [10.1016/0024-3205(95)00018-2].

The design of novel methoctramine-related tetraamines as muscarinic receptor subtype selective antagonists

Melchiorre C.;Minarini A.;Budriesi R.;Chiarini A.;Spampinato S.;Tumiatti V.
1995

Abstract

Several novel methoctramine-related tetraamines were designed, and their biological profiles at muscarinic receptor subtypes were assessed by functional experiments in isolated guinea pig and rat atria (M2) and smooth muscle (ileum and trachea, M3) and by binding assays in rat cortex (M1), heart (M2), and submaxillary gland (M3) homogenates and NG 108-15 cells (M4). Tripitramine, a nonsymmetrical tetraamine, resulted in the most potent and the most selective muscarinic M2 receptor antagonist of the series (pA2 = 9.14-9.85; pKi= 9.54). Spirotramine (FC 15-94), a symmetrical tetraamine, was able to differentiate between muscarinic m1 receptors (pKi = 7.88) and the other subtypes (M2, pKi = 6.20; M3, pKi =5.81; M4 pKi = 6.27). Thus, tripitramine and spirotramine could be valuable tools for the pharmacological classification and characterization of muscarinic receptor subtypes. © 1995.
1995
Melchiorre C., Minarini A., Budriesi R., Chiarini A., Spampinato S., Tumiatti V. (1995). The design of novel methoctramine-related tetraamines as muscarinic receptor subtype selective antagonists. LIFE SCIENCES, 56(11-12), 837-844 [10.1016/0024-3205(95)00018-2].
Melchiorre C.; Minarini A.; Budriesi R.; Chiarini A.; Spampinato S.; Tumiatti V.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/911652
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 10
social impact